Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Netherlands Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20034
20041
20053
20061
20072
20081
20092
20101
20114
20121
20135
20141
20152
20183
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Active, not recruiting3
Terminated3
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Boston Scientific Corporation3
Abbott Medical Devices2
Cordis US Corp.2
R&D Cardiologie2
Abiomed Inc.1
Air Liquide Santé International1
Alexion Pharmaceuticals, Inc.1
Amarin Pharma Inc.1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease37
Coronary Disease6
Cardiovascular Diseases5
Coronary Stenosis5
Heart Diseases5
Acute Coronary Syndrome4
Myocardial Infarction4
Myocardial Ischemia4
Stroke4
Vascular Diseases4

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.